Sales rise 31.15% to Rs 387.52 crore
Net loss of Astrazeneca Pharma India reported to Rs 11.79 crore in the quarter ended June 2024 as against net profit of Rs 53.86 crore during the previous quarter ended June 2023. Sales rose 31.15% to Rs 387.52 crore in the quarter ended June 2024 as against Rs 295.47 crore during the previous quarter ended June 2023. ParticularsQuarter EndedJun. 2024Jun. 2023% Var.Sales387.52295.47 31 OPM %9.8222.76 -PBDT46.3175.19 -38 PBT42.4071.40 -41 NP-11.7953.86 PLPowered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content